<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ctELM: Decoding and Manipulating Embeddings of Clinical Trials with Embedding Language Models - Health AI Hub</title>
    <meta name="description" content="This paper introduces ctELM, an Embedding Language Model (ELM) designed to decode and manipulate embeddings of clinical trials. ctELM enables accurate descripti">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>ctELM: Decoding and Manipulating Embeddings of Clinical Trials with Embedding Language Models</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.18796v1" target="_blank">2601.18796v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Brian Ondov, Chia-Hsuan Chang, Yujia Zhou, Mauro Giuffr√®, Hua Xu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CL, cs.AI, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.18796v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.18796v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces ctELM, an Embedding Language Model (ELM) designed to decode and manipulate embeddings of clinical trials. ctELM enables accurate description and comparison of unseen clinical trials from their embeddings and can generate plausible trial abstracts, demonstrating responsiveness to specific semantic concept vectors like age and sex. The work addresses the limited interpretability and generative capabilities of traditional text embeddings, offering a new tool for biomedical language applications.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research significantly advances the utility of clinical trial data by making their embedded representations interpretable and manipulable. It provides tools to quickly understand, compare, and even semantically modify trial characteristics, potentially streamlining meta-analyses, improving trial design, and facilitating the discovery of relevant studies for researchers and clinicians.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The ctELM model is an AI application designed to understand, interpret, and generate information about clinical trials from their embeddings. This can aid in various health applications such as: 1) Enhancing the design and planning of new clinical trials by allowing manipulation of parameters (e.g., patient demographics). 2) Facilitating the analysis and comparison of existing trials. 3) Potentially assisting in drug discovery and development by exploring plausible trial designs for novel compounds. 4) Improving the searchability and understanding of large datasets of clinical trials within the biomedical domain.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Problem Addressed:** Existing text embedding methods lack interpretability, explorability, and reversibility, limiting transparency and generative use cases, particularly in complex domains like clinical trials.</li>
                    
                    <li>**Solution Proposed:** Development of ctELM, an open-source, domain-agnostic Embedding Language Model (ELM) architecture and training framework specifically aligned with clinical trial embeddings.</li>
                    
                    <li>**Methodological Innovations:** The authors designed unique training tasks tailored for clinical trial data and created an expert-validated synthetic dataset to facilitate model training and evaluation.</li>
                    
                    <li>**Core Capabilities:** ctELM can accurately describe and compare unseen clinical trials by analyzing their embeddings alone, offering a powerful tool for semantic understanding and retrieval.</li>
                    
                    <li>**Generative Functionality:** The model demonstrates the ability to produce plausible, coherent clinical trial abstracts from novel (synthetic) embedding vectors, opening pathways for exploring hypothetical trial designs.</li>
                    
                    <li>**Semantic Manipulation:** A key finding is that generated trial abstracts are responsive to shifting embeddings along specific concept vectors, such as age and sex of study subjects, allowing for targeted modification of trial characteristics.</li>
                    
                    <li>**Open-Source Contribution:** The public release of the ELM implementation and experimental results aims to foster broader alignment of Large Language Models (LLMs) with embedding spaces within and beyond the biomedical domain.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved developing an open-source, domain-agnostic ELM architecture and training framework. Training tasks were specifically designed for clinical trials, complemented by an expert-validated synthetic dataset. A series of ELMs were trained to investigate the influence of different tasks and training regimes, culminating in the final ctELM model. The model's capabilities were validated by its ability to describe, compare, and generate plausible clinical trial abstracts from embeddings.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>ctELM can accurately describe and compare unseen clinical trials based solely on their embeddings. It possesses generative capabilities, producing plausible clinical trial abstracts from novel embedding vectors. Furthermore, generated abstracts are responsive to semantic manipulation along specific concept vectors, demonstrated for age and sex of study subjects, allowing for targeted modification of trial characteristics.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>ctELM has the potential to revolutionize how clinical trials are analyzed and designed. Clinicians and researchers could use it to rapidly understand the nuances of a trial from its embedding, semantically compare trials for meta-analysis, or explore the implications of modifying patient demographics (e.g., age or sex) on a hypothetical trial design. This could lead to more efficient trial design, better patient recruitment strategies, and improved evidence synthesis.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract, but common limitations for such models can include reliance on training data quality, potential for generating plausible but non-factual text, and the computational resources required for large-scale application.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors indicate that their public ELM implementation and experimental results will aid in the alignment of Large Language Models to embedding spaces in the biomedical domain and beyond. This suggests future work could involve applying ctELM to other types of biomedical text, extending its generative capabilities, and integrating it into broader clinical decision support or research platforms.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Clinical Research</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Evidence-Based Medicine</span>
                    
                    <span class="tag">Biomedical Informatics</span>
                    
                    <span class="tag">Trial Design</span>
                    
                    <span class="tag">Medical Data Science</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Embedding Language Model</span>
                    
                    <span class="tag tag-keyword">Clinical Trials</span>
                    
                    <span class="tag tag-keyword">Text Embeddings</span>
                    
                    <span class="tag tag-keyword">Generative AI</span>
                    
                    <span class="tag tag-keyword">Large Language Models</span>
                    
                    <span class="tag tag-keyword">Biomedical Informatics</span>
                    
                    <span class="tag tag-keyword">NLP</span>
                    
                    <span class="tag tag-keyword">Interpretability</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Text embeddings have become an essential part of a variety of language applications. However, methods for interpreting, exploring and reversing embedding spaces are limited, reducing transparency and precluding potentially valuable generative use cases. In this work, we align Large Language Models to embeddings of clinical trials using the recently reported Embedding Language Model (ELM) method. We develop an open-source, domain-agnostic ELM architecture and training framework, design training tasks for clinical trials, and introduce an expert-validated synthetic dataset. We then train a series of ELMs exploring the impact of tasks and training regimes. Our final model, ctELM, can accurately describe and compare unseen clinical trials from embeddings alone and produce plausible clinical trials from novel vectors. We further show that generated trial abstracts are responsive to moving embeddings along concept vectors for age and sex of study subjects. Our public ELM implementation and experimental results will aid the alignment of Large Language Models to embedding spaces in the biomedical domain and beyond.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>